(0) Write a review
In stock

Tirzepatide 30 Mg

Tirzepatide 30mg Dual Agonist Peptide

$159.00

16 products sold in last 24 hours
27 people are viewing this right now
Buy now
QuantityDiscountPrice
3–58%$146.28
6–910%$143.10
10+12%$139.92
Discount is applied automatically at checkout based on the quantity in your cart.
Ask Us
Product SpecificationTirzepatide 30mg / Lyophilized Powder Vial
Biochemical EngineDual GIP and GLP-1 Receptor Agonist Peptide
Primary Assay TargetInvestigated for synergistic incretin pathway activation, metabolic regulation, and energy homeostasis
Logistics ProfileTemperature-insulated, secure vacuum dispatch with complete tracking

STRICTLY FOR LABORATORY RESEARCH: This synthetic agent is processed strictly for institutional R&D, high-precision in vitro calibrations, and testing lines. Not for human therapeutic or diagnostic use.

Brand:

Description

Tirzepatide 30mg Core Specifications

Deep technical specification parameters optimized for integrating 30mg Tirzepatide into focused laboratory screening protocols.

Research ParameterAssay Benchmark ProfileInternal Catalog Link
Sequence BlueprintC-Terminal Acylated Polypeptide (Dual-Acting 39 Amino Acid Linear Base)High-Purity Series →
Molecular Weight4813.5 Da (Stabilized with a functional C20 fatty diacid tail chain)
Purity Baseline≥ 98.0% via High-Performance SEC-HPLCMetabolic – Fat Loss Series →
Assay TargetSynergistic GIP & GLP-1 Receptor Activation Loops (Zero CNS Shock)

Tirzepatide 30mg represents one of the most advanced examples of dual-incretin agonist technology—a 39-amino-acid acylated peptide compound synthesized to concurrently activate both GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor pathways. Unlike traditional single-receptor mimetics, this dual mechanism of action provides a broader range of analytical data in laboratory assays examining cellular glucose tolerance, insulin secretion dynamics, and adipose tissue metabolism. Formulated as a freeze-dried (lyophilized) sterile crystalline solid, this 30mg vial configuration offers optimal utility for mid-scale experimental series and multi-well test panels without compromising shelf life. To review verified analytical reports, please visit peptidesk.com.

Tirzepatide 30mg Technical Specifications

Technical PropertyLaboratory Standard Specifications
Chemical StructureAcylated 39-Amino Acid Dual Agonist Sequence
Active Core Payload30mg Lyophilized Crystalline Powder / Vial
Purity Baseline≥ 98.0% Pure Certified via HPLC & Mass Spectrometry
Primary Target NodeSynergistic GIP/GLP-1 receptor activation & adipocyte signaling

Research Compliance Notice: Compounds listed as tirzepatide research peptide for sale are intended strictly for in vitro cellular profiling, metabolic research, and laboratory assays. They are strictly not approved for clinical trial administration or human therapeutic use.

Tirzepatide Mechanism of Action: GLP-1 & GIP

Exploring the cellular tirzepatide mechanism of action highlights how dual receptor activation establishes a synergistic metabolic loop superior to traditional mono-agonist controls:

  • GIP Receptor Engagement: Direct binding to GIP receptors on pancreatic beta cells and adipose tissue matrices promotes glucose-dependent insulin release while directly regulating lipid storage pathways and metabolic flexibility.
  • GLP-1 Receptor Activation: Agonism at GLP-1 receptor locations prompts adenylate cyclase enzyme activity, raising intracellular cyclic AMP (cAMP) levels, delaying gastric motility, and signaling central appetite regulation nodes.
  • Metabolic Pathway Synergy: Concurrent activation across both incretin pathways yields greater glucose tolerance and fatty acid clearance speed than mono-agonist research baselines.

Tirzepatide Core Pathways & Action Matrix

Target PathwayObserved Cellular ActionPrimary Research Goal
Dual Incretin ActivationConcurrent stimulation of GIPR and GLP-1R backbones drives cAMP signaling.Analyzing dual-receptor cross-talk in cell cultures.
Adipocyte MetabolismAccelerates fatty acid oxidation and lipid mobilization in target cell lines.Measuring triglyceride breakdown rates natively.
Gastric Motility DelayTracks the rate of nutrient transit deceleration across gastrointestinal tissue models.Establishing comparative digestive transit curves.

Tirzepatide Weight Loss: Clinical Research & Results

Clinical trials investigating tirzepatide for weight loss models highlight marked reductions in total body mass, circulating visceral lipids, and systemic inflammatory markers. Key parameters documented across publication literature include:

  • Substantial Weight Reduction: In trial cohorts (such as the landmark SURMOUNT-1 study), high-dose maintenance protocols demonstrated weight loss percentages reaching over 20% across extended 72-week evaluation windows.
  • Cardiometabolic Biomarkers: Alongside total mass reduction, researchers recorded significant improvements in HbA1c levels, fasting insulin sensitivity, and circulating triglyceride balances.
  • Versatile 30mg Format: The 30mg vial serves as a highly efficient mid-tier configuration, offering ample active material for multi-week assay rows without the risk of long-term open-vial degradation.

Tirzepatide vs Mounjaro: What’s the Difference?

When analyzing mounjaro vs tirzepatide in scientific discussions, it is essential to distinguish between commercial finished pharmaceutical products and raw laboratory research reagents:

Comparison AttributeMounjaro / ZepboundTirzepatide 30mg Research Peptide
Active SequenceTirzepatide active chemical sequence.Identical 39-amino acid acylated sequence.
Delivery SystemPre-filled clinical single-dose autoinjector pen.Freeze-dried crystalline powder vial (30mg).
Application FieldClinical prescription therapy for T2D & obesity.In vitro research, receptor binding & cellular assays.

Tirzepatide vs Semaglutide: Weight Loss, Mechanism & Research

Comparing tirzepatide vs semaglutide demonstrates how multi-target agonism provides greater metabolic flexibility and glucose control than selective GLP-1 receptor activation alone:

CompoundTarget ReceptorsResearch BenchmarkStructure
Tirzepatide 30mg(Dual Agonist)GIPR + GLP-1RDual incretin engagement achieving superior metabolic & weight reduction data.39-AA Acylated Peptide
SemaglutideGLP-1R SelectiveMono-incretin standard evaluated across glucose management models.31-AA Acylated Peptide
Orforglipron 6mgGLP-1R (Oral)Non-peptide small molecule studied in oral transit modeling.Small Molecule

Tirzepatide vs Retatrutide: What’s the Difference?

When evaluating multi-receptor incretin agonists, researchers compare dual-action Tirzepatide (GIPR/GLP-1R) with triple-action Retatrutide (GIPR/GLP-1R/GCGR). While Tirzepatide balances insulin secretion and satiety signaling, Retatrutide’s addition of direct Glucagon receptor agonism further elevates lipid oxidation and basal energy expenditure in experimental models.

Tirzepatide Dosage: Clinical Dose Escalation Explained

In clinical research trial designs, establishing proper tirzepatide dosing follows a structured step-wise titration protocol to optimize receptor responsiveness while minimizing gastrointestinal friction:

  1. Initial Acclimation (Weeks 1–4): Initiated at a low baseline dose of 2.5mg weekly to allow target receptors to adapt smoothly.
  2. Incremental Titration (Weeks 5+): Increased by 2.5mg increments every 4 weeks (moving through 5mg, 7.5mg, 10mg, and 12.5mg steps).
  3. Maximum Maintenance Tier (15mg Weekly): Reaches maximum clinical maintenance levels at 15mg weekly for peak incretin pathway activation.

Tirzepatide Side Effects & Safety

Tracking potential tirzepatide side effects and safety profiles is a standard component of trial logging. Preclinical and clinical observations record the following parameters:

  • Gastrointestinal Effects: Transient nausea, vomiting, mild diarrhea, or constipation may occur, primarily during early dose escalation steps.
  • Systemic Tolerability: Mild fatigue or temporary headaches are occasionally noted secondary to rapid caloric intake reductions.
  • Protocol Mitigation: Adhering strictly to step-wise dose escalation significantly improves overall gastrointestinal tolerance.

Storage & Reconstitution Guidelines

  • FREEZER (-20°C)
    Lyophilized Powder: Keep dry powder vials stored in a laboratory freezer at -20°C to -80°C for long-term stability up to 24 months.
  • TRANSIT RESILIENCE
    Unreconstituted Powder: Highly stable during transit; can withstand ambient temperatures up to 25°C for up to 3 weeks. Freeze upon arrival.
  • REFRIGERATOR (2°C – 8°C)
    Reconstituted Solution: Store liquid solutions under refrigeration between 2°C and 8°C. Exhaust active liquid within 10 to 14 days. Do not refreeze.

Step-by-Step Reconstitution Protocol

  1. Allow the 30mg vial to naturally reach room temperature balance before removing the flip-off seal.
  2. Swab the rubber stopper using a sterile isopropyl alcohol wipe.
  3. Slowly inject sterile bacteriostatic water down the internal glass wall to prevent mechanical shock.
  4. Do not shake. Gently rotate the vial horizontally in circular concentric patterns until the white powder fully dissolves into a crystal-clear liquid.

Analytical Verification & Lab Reports: You can inspect our latest batch HPLC purity charts, mass spectrometry results, and independent Certificates of Analysis (COA) directly on our PeptidesK Third-Party Lab Testing Page.

To buy tirzepatide 30mg or source high-purity research compounds backed by certified batch HPLC reports and fast domestic shipping, order directly from peptidesk.com.

Shop by Goal Categories

Explore our high-purity research compounds and peptides categorized by primary experimental targets and research goals:

Goal CategoryPrimary Research Focus
Anti-Aging & Longevity Peptides →Cellular renewal, telomere maintenance, and anti-senescence research models.
Fat Loss & Metabolic Peptides →Incretin mimetics, lipolysis acceleration, and metabolic flexibility profiling.
Muscle Growth & Building Peptides →Anabolic signaling, GH secretagogues, and protein synthesis acceleration.
Recovery & Healing Peptides →Soft tissue repair, tendon-to-bone recovery, and systemic cell migration.
Focus & Cognitive Peptides →Nootropic signaling, neuroprotection, and synaptic plasticity assays.

Why Buy PeptidesK Tirzepatide 30mg Online?

Why Buy PeptidesK Tirzepatide 30mg Online?

For laboratories analyzing dual metabolic signaling pathways, acquiring highly pure dual GIP/GLP-1 receptor agonists is vital for verifiable analytical data. PeptidesK Tirzepatide 30mg delivers a standard-grade synthetic formulation engineered for high chemical stability and consistent in vitro receptor binding studies.

At PeptidesK, quality control is central to our supply process. Every production lot of Tirzepatide 30mg is independently tested to guarantee correct peptide sequence, precise filling weight, and high chemical purity. Sourcing reference material from PeptidesK assures your research facility receives reliable, batch-consistent compounds designed for rigorous lab testing.

Ordering reference peptides online through PeptidesK provides maximum security, convenience, and efficiency:

  • ✔ HPLC & MS Certified Purity: Comprehensive Certificates of Analysis (CoA) available for every research batch.
  • ✔ Fast & Express Shipping: Secure global dispatch with protective temperature-controlled packaging.
  • ✔ Competitive Pricing & Perks: Seamless order process, 24/7 dedicated support, and instant crypto checkout discounts.

Optimize your research outcomes today—order verified Tirzepatide 30mg directly from PeptidesK for swift delivery and guaranteed quality assurance.

Frequently Asked Questions (FAQ)

1. What is Tirzepatide 30mg and how is it used in research?

Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide. In scientific studies, it is investigated for its dual action on glucose homeostasis, insulin signaling, and energy expenditure pathways.

2. Why buy Tirzepatide 30mg from PeptidesK?

PeptidesK provides laboratory-verified purity standards, transparent CoA batch reporting, rapid dispatch, and secure checkout options tailored for research professionals.

3. What are the storage requirements for Tirzepatide 30mg?

Store lyophilized vials in a cool, dark, and dry environment. For maximum long-term shelf stability, keep the compound sealed at 2°C to 8°C in a temperature-monitored facility.

4. Can I request a Certificate of Analysis (CoA) for my batch?

Yes. Every lot of Tirzepatide 30mg sold by PeptidesK includes verified HPLC and Mass Spectrometry (MS) documentation confirming purity and identity.

5. How fast are orders processed and delivered?

All orders are packed discreetly and shipped within 24–48 hours. Express shipping options ensure fast domestic and international transit times.

6. Is Tirzepatide 30mg intended for human consumption?

No. All products on PeptidesK, including Tirzepatide 30mg, are strictly intended for laboratory, in-vitro, and scientific research purposes only.

Reviews

Be the first to review “Tirzepatide 30 Mg”

Your email address will not be published. Required fields are marked *

There are no reviews yet.

Search

Back to Top
Product has been added to your cart
Compare (0)